Reocclusion after thrombolysis

Autor: K Rübsamen, V Eschenfelder

Publikováno v: Blood Coagulation & Fibrinolysis. 2:97-100

The effect of recombinant hirudin (r-hir), unfractionated heparin (UFH) and acetylsalicylic acid (ASA) on the incidence of reocclusion after thrombolysis with plasminogen activator (rt-PA) was evaluated in anaesthetized rabbits. Formation of a platel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2281960c4991db7eead21c4d4802909f
https://doi.org/10.1097/00001721-199102000-00015

Title Page / Table of Contents, Vol. 21, Supplement 1, 1991

Autor: Kevin A. Mitchell, M. Spannagl, Melitta Just, Mark D. Talbot, J. Bichler, Ron Almquist, Paul H. Johnson, Cris Olsen, M. Koehler, Robert B. Wallis, F. Doutremepuich, C. Vigneron, G. Pindur, M. Siebeck, F. Markwardt, E. Wenzel, Michael Wallock, F.A. Ofosu, Ch. Rauschenbach, J.W. Fenton, Jawed Fareed, K. Stocker, G. Nowak, H. Bichler, H. Fritz, Fritz Markwardt, B. Schulz, J. Walenga, Keith D. Butler, C.M. Kirchmaier, Richard C. Winant, Michael Koza, Dominique Tripier, Ping Sze, K. Narayanan, M.D. Liang, W. Schramm, Christopher M. Lees, K. Rübsamen, P. Zeiller, Jerome B. Lazar, H. Lill, William S. Fields, E. Glusa, M. Basic-Micic, C. Kirchmaier, John Ambler, Morris F. Tweed, V. Eschenfelder, A. Morin, Peter Underhill, E. Bucha, W. Raake, B. Fichtl, G.B. Villanueva, O.K. Bellinger, H. Elling, K. Krupinski, C. Doutremepuich, Debra Hoppensteadt, B. Braun, Dirk Seiffge, Mike Koza, M.C. Lalanne, H.K. Breddin, Debra Hudson, J. Stürzebecher, M. Heiden, J.M. Walenga, M. Marchand-Arvier, Roque Pifarre, Robin F. Peters, Jeanine M. Walenga, K. Breddin, R.J. Klauser, J.M. Maraganore, J. Fareed

Publikováno v: Pathophysiology of Haemostasis and Thrombosis. 21:I-IV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::982bc78c67558a86681f7a8ed1feda41
https://doi.org/10.1159/000216257

Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation

Autor: K R, Karsch, M B, Preisack, R, Baildon, V, Eschenfelder, D, Foley, E J, Garcia, M, Kaltenbach, C, Meisner, H K, Selbmann, P W, Serruys, M F, Shiu, M, Sujatta, R, Bonan

Publikováno v: Journal of the American College of Cardiology. 28(6)

The specific objective of the REDUCE trial was to evaluate the effect of low molecular weight heparin on the incidence and occurrence of restenosis in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).Unfractionated heparin an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c80e52c5659c127fae9ac09f80f783ff
https://pubmed.ncbi.nlm.nih.gov/8917255

Pharmacokinetics of Clivarin a new low molecular weight heparin in healthy volunteers

Autor: J. Koderisch, K. Andrassy, V. Eschenfelder, E. Weber

Publikováno v: Thrombosis research. 73(2)

The antithrombotic activity and pharmacokinetics of Clivarin®, a low molecular weight heparin was randomly studied in 10 healthy male volunteers. Doses of 20, 40, 60 and 80 anti F Xa U/kg BW were injected intravenously and subcutaneously in crossove

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce4c4c4b9e5c409066217e5a7e5d3c7
https://pubmed.ncbi.nlm.nih.gov/7802862

Protein C depleted activated prothrombin complex neutralizes the bleeding associated with recombinant hirudin

Autor: J. Fareed, R. Pifarre, D. Hoppensteadt, V. Eschenfelder, J.M. Walenga, T. Stuever

Publikováno v: Fibrinolysis. 8:69

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dbc62e325b2217b6be9653684ae91ba8
https://doi.org/10.1016/0268-9499(94)90475-8